Charlier Nicolas, Préat Véronique, Gallez Bernard
Laboratory of Medicinal Chemistry and Radiopharmacy, Biomedical Resonance Unit, Université Catholique de Louvain, Brussels, Belgium.
Magn Reson Med. 2006 Jan;55(1):215-8. doi: 10.1002/mrm.20746.
The success of spin trapping techniques in vivo hinges on whether spin traps with high trapping efficiency and biocompatibility can be developed. Currently, two iron chelates based on the dithiocarbamate structure (hydrophilic ferro-di(N-methyl-D-glucamine-dithiocarbamate, or Fe(II)-MGD, and lipophilic ferro-di(diethyldithiocarbamate), or Fe(II)-DETC), are used for spin trapping of nitric oxide (NO) in biologic systems. However, detection efficiency is hampered by a complex redox chemistry for Fe(II)-MGD and by the insolubility of Fe(II)-DETC in water. To circumvent these problems, two new spin trap formulations based on Fe(II)-DETC were developed: a lipid-based carrier system stabilized by lecithin and inclusion complexes in hydroxypropyl-beta-cyclodextrin. The capability of these two systems to trap NO was determined and compared to the standard spin traps in vitro (in the presence of an NO donor) and in vivo (after induction of septic shock in mice). The sensitivity of the detection of NO was significantly increased (by a factor of 4) using the lipid-based carrier systems or inclusion complexes compared to the standard spin trap agents.
自旋捕获技术在体内的成功取决于能否开发出具有高捕获效率和生物相容性的自旋捕获剂。目前,两种基于二硫代氨基甲酸盐结构的铁螯合物(亲水性的铁 - 二(N - 甲基 - D - 葡糖胺二硫代氨基甲酸盐),即Fe(II)-MGD,以及亲脂性的铁 - 二(二乙二硫代氨基甲酸盐),即Fe(II)-DETC)被用于生物系统中一氧化氮(NO)的自旋捕获。然而,Fe(II)-MGD复杂的氧化还原化学性质以及Fe(II)-DETC在水中的不溶性阻碍了检测效率。为了解决这些问题,基于Fe(II)-DETC开发了两种新的自旋捕获剂配方:一种由卵磷脂稳定的脂质载体系统和羟丙基 - β - 环糊精包合物。测定了这两种系统捕获NO的能力,并在体外(在存在NO供体的情况下)和体内(在小鼠诱导败血性休克后)与标准自旋捕获剂进行了比较。与标准自旋捕获剂相比,使用脂质载体系统或包合物时,NO检测的灵敏度显著提高(提高了4倍)。